Information Library
Hear From the Experts
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
Late Phase Patient Reported Outcomes
November 4, 2009
Applied Clinical Trials October 2009 -
Late Phase Studies: An Early Priority
November 4, 2009
Next Generation Pharmaceutical, Q4 2009 -
Sound responses to the changing late-phase game
November 4, 2009
Next Generation Pharmaceutical, Q3 2009 -
Role of Clinical Educator
October 14, 2009
Podcast explains reasons for non-compliance and the role of a Clinical Educator to help improve patient adherence to therapy. Customer gives real-world example of successful program -
Enhancing a Culture of Safety in the Life Sciences Sector
October 6, 2009
Axel Olsen, Executive Director of Global Pharmacovigilance and Risk Management, stresses that stakeholder collaboration is the key to improving drug safety. -
Patient-centric Services Europe
September 24, 2009
What does the term HMS stand for and what exactly are patient-centric programs? Who benefits and how do successful programs look like? Germany and UK are used to demonstrate effectiveness of these programs. -
Comparative Effectiveness Research as a Drug Development Tool
September 1, 2009
A Q&A with John Doyle, Vice President and Practice Leader of Quintiles Consulting, sheds light on the complex issue of comparative effectiveness research, and its strategic importance in successful and efficient biopharmaceutical development. -
Changing the Face of Cancer Research
August 31, 2009
Christopher Ung, Vice President, Strategic Business & Operations, Oncology, at TMD, a Quintiles Central Laboratory, explains how advances in biomarker technology are ushering in a new era of cancer therapy development. -
Why the pharmaceutical industry needs to evolve to meet its current challenges.
August 14, 2009
The industry is looking for a miracle to help it deal with the contracting drug pipeline and competition from generics. But, argues Daryl Gaugler President of Innovex, the answer lies not in divine intervention but in a different type of sales team for the future – one that is both more flexible... and more diverse. -
Knocking on a difficult door
August 14, 2009
The role of the payor in determining treatment paradigms for patients is growing globally.